Dermatology Unit, Topical Drug Delivery & DMPK, GlaxoSmithKline, Collegeville, Pennsylvania.
Current affiliation: Incyte Corporation, Inflammation & AutoImmunity, Clinical Research, Wilmington, Delaware.
Curr Protoc Pharmacol. 2020 Dec;91(1):e79. doi: 10.1002/cpph.79.
In vitro assessment of topical (dermal) pharmacokinetics is a critical aspect of the drug development process for semi-solid products (e.g., solutions, foams, sprays, creams, gels, lotions, ointments), allowing for informed selection of new chemical entities, optimization of prototype formulations during the nonclinical stage, and determination of bioequivalence of generics. It can also serve as a tool to further understand the impact of different excipients on drug delivery, product quality, and formulation microstructure when used in parallel with other techniques, such as analyses of rheology, viscosity, microscopic characteristics, release rate, particle size, and oil droplet size distribution. The in vitro permeation test (IVPT), also known as in vitro skin penetration/permeation test, typically uses ex vivo human skin in conjunction with diffusion cells, such as Franz (or vertical) or Bronaugh (or flow-through) diffusion cells, and is the technique of choice for dermal pharmacokinetics assessment. Successful execution of the IVPT also involves the development and use of fit-for-purpose bioanalytical methods and procedures. The protocols described herein provide detailed steps for execution of the IVPT utilizing flow-through diffusion cells and for key aspects of the development of a liquid chromatography-tandem mass spectrometry method intended for analysis of the generated samples (epidermis, dermis, and receptor solution). © 2020 Wiley Periodicals LLC. Basic Protocol 1: In vitro permeation test Support Protocol: Dermatoming of ex vivo human skin Basic Protocol 2: Bioanalytical methodology in the context of the in vitro permeation test.
体外(皮肤)药代动力学评估是半固体制剂(例如溶液、泡沫、喷雾剂、乳膏、凝胶、洗剂、软膏)药物开发过程中的一个关键方面,可用于明智地选择新的化学实体、在非临床阶段优化原型制剂,并确定仿制药的生物等效性。当与流变学分析、粘度、微观特征、释放率、粒径和油滴粒径分布等其他技术一起使用时,它还可以作为一种工具,用于进一步了解不同赋形剂对药物传递、产品质量和制剂微观结构的影响。体外渗透试验(IVPT),也称为体外皮肤渗透/渗透试验,通常使用离体人皮肤与扩散池(例如 Franz(或垂直)或 Bronaugh(或流通)扩散池)一起使用,是评估皮肤药代动力学的首选技术。成功执行 IVPT 还涉及开发和使用适合目的的生物分析方法和程序。本文所述的方案提供了使用流通扩散池执行 IVPT 的详细步骤,以及用于开发旨在分析生成样品(表皮、真皮和受体溶液)的液相色谱-串联质谱方法的关键方面。© 2020 威利父子公司。基本方案 1:体外渗透试验支持方案:离体人皮肤的皮肤分层基本方案 2:体外渗透试验背景下的生物分析方法。